Akorn Receives Second Warning Letter In Six Months

After receiving multiple Form 483s, Akorn receives yet another warning letter in the span of six months from the US Food and Drug Administration. 

Warning
Akorn has received an FDA warning letter for its facility in Somerset, New Jersey • Source: Shutterstock

More from Manufacturing

More from Business